Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome

William W. Hurd, Mohamed Y. Abdel-Rahman, Salah A. Ismail, Mostafa A. Abdellah, Christine L. Schmotzer, Ajay Sood

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: To compare screening strategies for type 2 diabetes mellitus (DM), impaired glucose tolerance (pre-DM), and insulin resistance (IR) in women with polycystic ovary syndrome (PCOS). Design: Prospective study. Setting: Academic reproductive endocrinology practice. Patient(s): Adult women with PCOS (n = 111). Intervention(s): None. Main Outcome Measure(s): Subjects were screened for pre-DM and DM using a 2-hour glucose tolerance test (GTT), hemoglobin A1c (HbA1c), or fasting plasma glucose (FPG) and for IR using homeostasis model assessment (HOMA), insulin levels (fasting and 2 hours after 75 glucose load), or obesity. Screening approaches were compared using positive and negative percent agreement and Cohen's kappa (κ). Result(s): DM and pre-DM were diagnosed by GTT in 4% and 20% of subjects, respectively. Screening with FPG failed to identify 41% of pre-DM and 20% of DM subjects. GTT and HbA1c had only fair agreement (κ = 0.29). IR was diagnosed in 24% of subjects with pre-DM or DM and in 56% of the remaining subjects using HOMA and insulin levels. HOMA and elevated insulin levels demonstrated substantial agreement for detecting IR (κ = 0.70-0.73). Obesity demonstrated fair to slight agreement (κ = 0.33-0.18). Conclusion(s): Women with PCOS should be screened for Pre-DM and DM using GTT or HbA1c, and those with Pre-DM or DM are presumed to have IR. In the rest, IR can be detected using either HOMA or insulin levels.

Original languageEnglish (US)
Pages (from-to)1043-1047
Number of pages5
JournalFertility and Sterility
Volume96
Issue number4
DOIs
StatePublished - Oct 1 2011
Externally publishedYes

Fingerprint

Polycystic Ovary Syndrome
Insulin Resistance
Diabetes Mellitus
Glucose Tolerance Test
Homeostasis
Insulin
Fasting
Hemoglobins
Glucose
Obesity
Glucose Intolerance
Endocrinology
Type 2 Diabetes Mellitus

Keywords

  • blood glucose
  • hemoglobin A1c
  • insulin resistance
  • oral glucose tolerance test
  • Polycystic ovarian syndrome
  • type 2 diabetes mellitus

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome. / Hurd, William W.; Abdel-Rahman, Mohamed Y.; Ismail, Salah A.; Abdellah, Mostafa A.; Schmotzer, Christine L.; Sood, Ajay.

In: Fertility and Sterility, Vol. 96, No. 4, 01.10.2011, p. 1043-1047.

Research output: Contribution to journalArticle

Hurd, William W. ; Abdel-Rahman, Mohamed Y. ; Ismail, Salah A. ; Abdellah, Mostafa A. ; Schmotzer, Christine L. ; Sood, Ajay. / Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome. In: Fertility and Sterility. 2011 ; Vol. 96, No. 4. pp. 1043-1047.
@article{01f06fd46788461faa9233893291c6cd,
title = "Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome",
abstract = "Objective: To compare screening strategies for type 2 diabetes mellitus (DM), impaired glucose tolerance (pre-DM), and insulin resistance (IR) in women with polycystic ovary syndrome (PCOS). Design: Prospective study. Setting: Academic reproductive endocrinology practice. Patient(s): Adult women with PCOS (n = 111). Intervention(s): None. Main Outcome Measure(s): Subjects were screened for pre-DM and DM using a 2-hour glucose tolerance test (GTT), hemoglobin A1c (HbA1c), or fasting plasma glucose (FPG) and for IR using homeostasis model assessment (HOMA), insulin levels (fasting and 2 hours after 75 glucose load), or obesity. Screening approaches were compared using positive and negative percent agreement and Cohen's kappa (κ). Result(s): DM and pre-DM were diagnosed by GTT in 4{\%} and 20{\%} of subjects, respectively. Screening with FPG failed to identify 41{\%} of pre-DM and 20{\%} of DM subjects. GTT and HbA1c had only fair agreement (κ = 0.29). IR was diagnosed in 24{\%} of subjects with pre-DM or DM and in 56{\%} of the remaining subjects using HOMA and insulin levels. HOMA and elevated insulin levels demonstrated substantial agreement for detecting IR (κ = 0.70-0.73). Obesity demonstrated fair to slight agreement (κ = 0.33-0.18). Conclusion(s): Women with PCOS should be screened for Pre-DM and DM using GTT or HbA1c, and those with Pre-DM or DM are presumed to have IR. In the rest, IR can be detected using either HOMA or insulin levels.",
keywords = "blood glucose, hemoglobin A1c, insulin resistance, oral glucose tolerance test, Polycystic ovarian syndrome, type 2 diabetes mellitus",
author = "Hurd, {William W.} and Abdel-Rahman, {Mohamed Y.} and Ismail, {Salah A.} and Abdellah, {Mostafa A.} and Schmotzer, {Christine L.} and Ajay Sood",
year = "2011",
month = "10",
day = "1",
doi = "10.1016/j.fertnstert.2011.07.002",
language = "English (US)",
volume = "96",
pages = "1043--1047",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome

AU - Hurd, William W.

AU - Abdel-Rahman, Mohamed Y.

AU - Ismail, Salah A.

AU - Abdellah, Mostafa A.

AU - Schmotzer, Christine L.

AU - Sood, Ajay

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Objective: To compare screening strategies for type 2 diabetes mellitus (DM), impaired glucose tolerance (pre-DM), and insulin resistance (IR) in women with polycystic ovary syndrome (PCOS). Design: Prospective study. Setting: Academic reproductive endocrinology practice. Patient(s): Adult women with PCOS (n = 111). Intervention(s): None. Main Outcome Measure(s): Subjects were screened for pre-DM and DM using a 2-hour glucose tolerance test (GTT), hemoglobin A1c (HbA1c), or fasting plasma glucose (FPG) and for IR using homeostasis model assessment (HOMA), insulin levels (fasting and 2 hours after 75 glucose load), or obesity. Screening approaches were compared using positive and negative percent agreement and Cohen's kappa (κ). Result(s): DM and pre-DM were diagnosed by GTT in 4% and 20% of subjects, respectively. Screening with FPG failed to identify 41% of pre-DM and 20% of DM subjects. GTT and HbA1c had only fair agreement (κ = 0.29). IR was diagnosed in 24% of subjects with pre-DM or DM and in 56% of the remaining subjects using HOMA and insulin levels. HOMA and elevated insulin levels demonstrated substantial agreement for detecting IR (κ = 0.70-0.73). Obesity demonstrated fair to slight agreement (κ = 0.33-0.18). Conclusion(s): Women with PCOS should be screened for Pre-DM and DM using GTT or HbA1c, and those with Pre-DM or DM are presumed to have IR. In the rest, IR can be detected using either HOMA or insulin levels.

AB - Objective: To compare screening strategies for type 2 diabetes mellitus (DM), impaired glucose tolerance (pre-DM), and insulin resistance (IR) in women with polycystic ovary syndrome (PCOS). Design: Prospective study. Setting: Academic reproductive endocrinology practice. Patient(s): Adult women with PCOS (n = 111). Intervention(s): None. Main Outcome Measure(s): Subjects were screened for pre-DM and DM using a 2-hour glucose tolerance test (GTT), hemoglobin A1c (HbA1c), or fasting plasma glucose (FPG) and for IR using homeostasis model assessment (HOMA), insulin levels (fasting and 2 hours after 75 glucose load), or obesity. Screening approaches were compared using positive and negative percent agreement and Cohen's kappa (κ). Result(s): DM and pre-DM were diagnosed by GTT in 4% and 20% of subjects, respectively. Screening with FPG failed to identify 41% of pre-DM and 20% of DM subjects. GTT and HbA1c had only fair agreement (κ = 0.29). IR was diagnosed in 24% of subjects with pre-DM or DM and in 56% of the remaining subjects using HOMA and insulin levels. HOMA and elevated insulin levels demonstrated substantial agreement for detecting IR (κ = 0.70-0.73). Obesity demonstrated fair to slight agreement (κ = 0.33-0.18). Conclusion(s): Women with PCOS should be screened for Pre-DM and DM using GTT or HbA1c, and those with Pre-DM or DM are presumed to have IR. In the rest, IR can be detected using either HOMA or insulin levels.

KW - blood glucose

KW - hemoglobin A1c

KW - insulin resistance

KW - oral glucose tolerance test

KW - Polycystic ovarian syndrome

KW - type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=80053305605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053305605&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2011.07.002

DO - 10.1016/j.fertnstert.2011.07.002

M3 - Article

C2 - 21813121

AN - SCOPUS:80053305605

VL - 96

SP - 1043

EP - 1047

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 4

ER -